Fate Therapeutics, Inc. (FATE)
2.08
-0.09
(-4.15%)
USD |
NASDAQ |
Oct 30, 16:00
2.09
+0.01
(+0.48%)
After-Hours: 20:00
Fate Therapeutics 30-Day Average Daily Volume : 1.299M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.299M |
| October 29, 2026 | 1.403M |
| October 28, 2026 | 1.548M |
| October 27, 2026 | 1.554M |
| October 26, 2026 | 1.550M |
| October 23, 2026 | 1.523M |
| October 22, 2026 | 1.511M |
| October 21, 2026 | 1.507M |
| October 20, 2026 | 1.485M |
| October 19, 2026 | 1.490M |
| October 16, 2026 | 1.454M |
| October 15, 2026 | 1.432M |
| October 14, 2026 | 1.434M |
| October 13, 2026 | 1.413M |
| October 12, 2026 | 1.399M |
| October 09, 2026 | 1.403M |
| October 08, 2026 | 1.429M |
| October 07, 2026 | 1.415M |
| October 06, 2026 | 1.468M |
| October 05, 2026 | 1.473M |
| October 02, 2026 | 1.417M |
| October 01, 2026 | 1.448M |
| September 30, 2026 | 1.461M |
| September 29, 2026 | 1.457M |
| September 28, 2026 | 1.515M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.543M |
| September 24, 2026 | 1.509M |
| September 23, 2026 | 1.510M |
| September 22, 2026 | 1.523M |
| September 21, 2026 | 1.532M |
| September 18, 2026 | 1.624M |
| September 17, 2026 | 1.559M |
| September 16, 2026 | 1.500M |
| September 15, 2026 | 1.672M |
| September 14, 2026 | 1.687M |
| September 11, 2026 | 1.714M |
| September 10, 2026 | 1.746M |
| September 09, 2026 | 1.756M |
| September 08, 2026 | 1.800M |
| September 04, 2026 | 1.754M |
| September 03, 2026 | 1.769M |
| September 02, 2026 | 1.800M |
| September 01, 2026 | 1.809M |
| August 31, 2026 | 1.812M |
| August 28, 2026 | 1.843M |
| August 27, 2026 | 1.875M |
| August 26, 2026 | 1.996M |
| August 25, 2026 | 2.025M |
| August 24, 2026 | 2.007M |
| August 21, 2026 | 2.164M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AVITA Medical, Inc. | 390677.3 |
| Agenus, Inc. | 990662.5 |
| Amgen, Inc. | 2.742M |
| Anika Therapeutics, Inc. | 102338.5 |
| BioCryst Pharmaceuticals, Inc. | 5.120M |